The severe respiratory illness due to SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19), is triggered by an intense pro-inflammatory host response. Statins, prescribed primarily for lipid reduction, are known to have anti-inflammatory and immunomodulatory properties and have been associated with a reduced mortality rate among COVID-19 patients taking statins as reported in two recent retrospective studies. However, a meta-analysis that included nine studies showed that statin use did not improve in-hospital outcomes of those with COVID-19. In addition, concerns regarding the use of statins and an increase in COVID-19 infections have been raised, as statins may increase the expression of angiotensin-converting enzyme 2 (ACE2), the primary receptor for the SARS-CoV-2 virus. Our goal was to investigate the effect of statins in COVID-19 patients in a large, diverse patient population across the United States containing nearly 120,000 patients diagnosed with COVID-19. We used propensity score matching of demographics, comorbidities, and medication indication to compare statin-treated patients ( N = 2,297) with matched controls ( N = 4,594). We observed a small, but statistically significant, decrease in mortality among patients prescribed statins (16.1%) when compared with matched COVID-19-positive controls (18.0 to 20.6%). These results support previous evidence that statins do not increase COVID-19-related mortality and may, in fact, have a mitigating effect on severity of the disease reflected in a slight reduction in mortality. Mixed findings on effects of statins in COVID-19 patients reported in the literature should prompt prospective randomized controlled trials in order to define better who might be advantaged with respect to clinical outcomes.
【저자키워드】 COVID-19, SARS-CoV-2, oxidative stress, mortality rate, statins, Inflammatory response, Electronic health records, 【초록키워드】 Randomized controlled trial, coronavirus disease, Meta-analysis, ACE2, Mortality, Anti-inflammatory, severity, Comorbidities, host response, outcome, virus, angiotensin-converting enzyme 2, clinical outcomes, COVID-19 infection, Patient, Control, receptor, medication, severe respiratory illness, expression, Evidence, retrospective, propensity score matching, COVID-19 patient, demographics, Support, reduction, In-hospital, patient population, reduction in mortality, pro-inflammatory, Effect, decrease, IMPROVE, responsible, reported, the United State, addition, the disease, raised, nine, reduced, reflected, increase in, to define, triggered, statistically significant, diagnosed with COVID-19, immunomodulatory property, the SARS-CoV-2 virus, with COVID-19, 【제목키워드】 Record, Rate, Decreased,